НТФФ Полисан - фармацевтическое производство

protection of health


Production involving existing process lines

Key contract manufacturing directions: tablets, solution for infusions, intravenous and intramuscular solutions.
Existing production capacities comply with Russian GMP (as of 2017), Belarus GMP (as of 2016), Chile GMP (2017), ISO 9001 and 14001 requirements.

Strategic partnership

It is possible to establish a brand-new production line based on the customer requirements and to produce various dosage forms within 1800 m² GxP-compliant production area. Construction of a new production building is possible.

Science and innovations (CDMO)

Development of new dosage forms with a focus on further manufacturing in POLYSAN.
Development of drug products nonregistered in Russia with a focus on further manufacturing of the local product.

Our advantages

- compliance with GMP standards,
- experience in contract manufacturing projects in partnership with global pharma companies
- full production cycle for finished dosage forms, possibility of API synthesis localization
- product development and registration ensuring the “local product” status
- own R&D-dedicated building,
- high production quality confirmed by contract manufacturing partners
- advanced European equipment in the production lines.